From: The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study
Biomarkers Evaluated
R Value
pValue**
ER to PR
0.638
0.000
ER to HER2
-0.228
0.013
ER to GST-pi
-0.254
0.005
ER to Topo-II
-0.261
0.004
GST-pi to MRP
0.251
0.006
HER2 to Topo-II
0.204
0.027